DMT is a biotechnology and bioengineering company with more than twenty years of experience in the development and manufacture of myograph equipment designed for the in vitro assessment of vascular structure and function.

Historically, myography development closely mirrors the scientific discoveries of the 1980s and 1990s when the basic mechanisms underlying the development of vascular changes in hypertension, diabetes and ateriosclerosis were elucidated. We have integrated the needs of the user with first class mechanical, electrical and software engineering to become one of the world's leading designers and manufacturer of wire and pressure myographs and tissue organ bath systems.

 

In this role, driven by the requirements of our large global customer base, we also hold an extensive portfolio of developing technologies including surgical, electrophysiological, pharmacological and physiological tools used by the research community and the pharmaceutical industry.